Enliven Therapeutics, Inc.

EX-3.1 · d152745dex31.htm

EX-3.1
 2
 d152745dex31.htm
 EX-3.1

 Exhibit 3.1

 CERTIFICATE OF AMENDMENT TO THE RESTATED CERTIFICATE OF

 INCORPORATION OF ENLIVEN THERAPEUTICS, INC.

 (Pursuant to Section 242 of the
 General
Corporation Law of the State of Delaware)
 Enliven Therapeutics, Inc., a corporation organized and existing under the laws of the State of
Delaware (the “Corporation”), DOES HEREBY CERTIFY:

 1.
 The name of the Corporation is Enliven Therapeutics, Inc. The Corporation’s original Certificate of Incorporation
was filed with the Secretary of State of the State of Delaware on January 26, 2016 under the name IMARA Inc.

 2.
 This Certificate of Amendment to the Restated Certificate of Incorporation of the Corporation has been duly adopted in
accordance with the applicable provisions of Section 242 of the Delaware General Corporation Law of the State of Delaware, by the Board of Directors and the stockholders of the Corporation.

 3.
 The first three paragraphs of Article FOURTH of the Corporation’s certificate of incorporation are hereby amended
and restated in their entirety to read as follows:

 “FOURTH: The total number of shares of all classes of stock which the
Corporation shall have authority to issue is 210,000,000 shares, consisting of

 (i)
 200,000,000 shares of Common Stock, $0.001 par value per share (“Common Stock”) and

 (ii)
 10,000,000 shares of Preferred Stock, $0.001 par value per share (“Preferred Stock”).”

 IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by a duly
authorized officer of the Corporation on June 9, 2026.

 By:

 /s/ Richard Fair

 Richard Fair, President and Chief Executive Officer